Prism Pharmaceuticals
King Of Prussia, Pennsylvania, United States
About Prism Pharmaceuticals
Prism Pharmaceuticals, Inc., an acute care pharmaceutical company, engages in developing and commercializing cardiovascular injectable products in the United States. Its products include NEXTERONE, an anti arrhythmic agent in the form of injectable amiodarone; and PM103, an intravenous formulation of clopidogrel bisulfate. The company was founded in 2004 and is based in King of Prussia, Pennsylvania.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $80.0M
- Funding stage: M&A
- Last round: Series C (Jun 2013)
- Website: prismpharma.com
- Phone: (610) 265-7710
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/prism-pharmaceuticals-2570857 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.